Infliximab Concentrations in Participants with Moderate to Severe COVID-19

被引：1
|
作者：
Balevic, Stephen J. [1 ,2 ,8 ,9 ]
Dandachi, Dima [3 ]
Dixon, Danielle [4 ]
Hoetelmans, Richard M. W. [5 ]
Bozzette, Sam [6 ]
Mccarthy, Matthew W. [7 ]
机构：
[1] Duke Univ, Sch Med, Dept Med, Durham, NC USA
[2] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[3] Univ Missouri Columbia, Columbia, MO USA
[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
[5] Janssen Infect Dis BVBA, Beerse, Belgium
[6] Natl Ctr Advancing Translat Sci, Bethesda, MD USA
[7] Weill Cornell Med, New York, NY USA
[8] Duke Univ, Dept Med, Sch Med, 2301 Erwin Rd,T0909, Durham, NC 27710 USA
[9] Duke Univ, Dept Pediat, Sch Med, 2301 Erwin Rd,T0909, Durham, NC 27710 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2024年 / 64卷 / 04期
关键词：
COVID-19; infliximab; pharmacokinetics;
D O I：
10.1002/jcph.2388
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：490 / 491
页数：2
相关论文
共 50 条
  • [41] High incidence of venous thrombosis in patients with moderate-to-severe COVID-19
    Kerbikov, Oleg
    Orekhov, Pavel
    Borskaya, Ekaterina
    Nosenko, Natalia
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 344 - 347
  • [42] High incidence of venous thrombosis in patients with moderate-to-severe COVID-19
    Oleg Kerbikov
    Pavel Orekhov
    Ekaterina Borskaya
    Natalia Nosenko
    [J]. International Journal of Hematology, 2021, 113 : 344 - 347
  • [43] Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study
    Chilimuri, Sridhar
    Sun, Haozhe
    Alemam, Ahmed
    Kang, Kyoung-Sil
    Lao, Peter
    Mantri, Nikhitha
    Schiller, Lawrence
    Sharabun, Myroslava
    Shehi, Elona
    Tejada, Jairo
    Yugay, Alla
    Nayudu, Suresh Kumar
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 440 - 446
  • [44] Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis
    Congly, Stephen E.
    Varughese, Rhea A.
    Brown, Crystal E.
    Clement, Fiona M.
    Saxinger, Lynora
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Antibody Cocktail in Moderate to Severe COVID-19 Infection: A Series of 10 Cases
    Bhandari, Rohit Hanmanta
    Gupta, Sonali
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (06) : UR1 - UR3
  • [46] Increased KL-6 levels in moderate to severe COVID-19 infection
    Cambier, Maureen
    Henket, Monique
    Frix, Anne Noelle
    Gofflot, Stephanie
    Thys, Marie
    Tomasetti, Sara
    Peired, Anna
    Struman, Ingrid
    Rousseau, Anne-Francoise
    Misset, Benoit
    Darcis, Gilles
    Moutschen, Michel
    Louis, Renaud
    Njock, Makon-Sebastien
    Cavalier, Etienne
    Guiot, Julien
    [J]. PLOS ONE, 2022, 17 (11):
  • [47] Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
    Darazam, Ilad Alavi
    Shokouhi, Shervin
    Mardani, Masoud
    Pourhoseingholi, Mohamad Amin
    Rabiei, Mohammad Mahdi
    Hatami, Firouze
    Shabani, Minoosh
    Moradi, Omid
    Gharehbagh, Farid Javandoust
    Irvani, Seyed Sina Naghibi
    Amirdosara, Mahdi
    Hajiesmaeili, Mohammadreza
    Rezaei, Omidvar
    Khoshkar, Ali
    Lotfollahi, Legha
    Gachkar, Latif
    Dehbsneh, Hadiseh Shabanpour
    Khalili, Negar
    Soleymaninia, Azam
    Kusha, Akram Hoseyni
    Shoushtari, Maryam Taleb
    Torabinavid, Parham
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [48] Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19
    Zendelovska, Dragica
    Atanasovska, Emilija
    Petrushevska, Marija
    Spasovska, Katerina
    Stevanovikj, Milena
    Demiri, Ilir
    Labachevski, Nikola
    [J]. ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2021, 59 (04) : 375 - 383
  • [49] Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes
    Louhaichi, Sabrine
    Belkhir, Safa
    Khalfallah, Ikbelle
    Boubaker, Nouha
    Ferchichi, Mariem
    Ammar, Jamel
    Hamdi, Besma
    Hamzaoui, Agnes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [50] Intravascular volume status in patients with moderate to severe COVID-19: a case series
    Akbari, Hamideh
    Safaei, Arash
    Akhgar, Atousa
    [J]. FRONTIERS IN EMERGENCY MEDICINE, 2024, 8 (03):
12345